134 related articles for article (PubMed ID: 6798992)
1. Anthramycin binding to deoxyribonucleic acid-mitomycin C complexes. Evidence for drug-induced deoxyribonucleic acid conformational change and cooperativity in mitomycin C binding.
Kaplan DJ; Hurley LH
Biochemistry; 1981 Dec; 20(26):7572-80. PubMed ID: 6798992
[TBL] [Abstract][Full Text] [Related]
2. Conformations of complexes between pyrrolo[1,4]benzodiazepines and DNA segments.
Remers WA; Mabilia M; Hopfinger AJ
J Med Chem; 1986 Dec; 29(12):2492-503. PubMed ID: 3783609
[TBL] [Abstract][Full Text] [Related]
3. Altered physiochemical properties of the deoxyribonucleic acid-mitomycin C complex. Evidence for the conformational change in deoxyribonucleic acid.
Kaplan DJ; Tomasz M
Biochemistry; 1982 Jun; 21(12):3006-13. PubMed ID: 6809044
[TBL] [Abstract][Full Text] [Related]
4. Pyrrolo(1,4)benzodiazepine antitumor antibiotics. In vitro interaction of anthramycin, sibiromycin and tomaymycin with DNA using specifically radiolabelled molecules.
Hurley LH; Gairola C; Zmijewski M
Biochim Biophys Acta; 1977 Apr; 475(3):521-35. PubMed ID: 15599
[TBL] [Abstract][Full Text] [Related]
5. DNA sequence specificity of the pyrrolo[1,4]benzodiazepine antitumor antibiotics. Methidiumpropyl-EDTA-iron(II) footprinting analysis of DNA binding sites for anthramycin and related drugs.
Hertzberg RP; Hecht SM; Reynolds VL; Molineux IJ; Hurley LH
Biochemistry; 1986 Mar; 25(6):1249-58. PubMed ID: 3008824
[TBL] [Abstract][Full Text] [Related]
6. Correlation of DNA sequence specificity of anthramycin and tomaymycin with reaction kinetics and bending of DNA.
Kizu R; Draves PH; Hurley LH
Biochemistry; 1993 Aug; 32(33):8712-22. PubMed ID: 8357813
[TBL] [Abstract][Full Text] [Related]
7. Structure of the anthramycin-d(ATGCAT)2 adduct from one- and two-dimensional proton NMR experiments in solution.
Graves DE; Stone MP; Krugh TR
Biochemistry; 1985 Dec; 24(26):7573-81. PubMed ID: 4092025
[TBL] [Abstract][Full Text] [Related]
8. Anthramycin inhibition of restriction endonuclease cleavage and its use as a reversible blocking agent in DNA constructions.
Sumner W; Bennett GN
Nucleic Acids Res; 1981 May; 9(9):2105-19. PubMed ID: 6272225
[TBL] [Abstract][Full Text] [Related]
9. Crystal structure of a covalent DNA-drug adduct: anthramycin bound to C-C-A-A-C-G-T-T-G-G and a molecular explanation of specificity.
Kopka ML; Goodsell DS; Baikalov I; Grzeskowiak K; Cascio D; Dickerson RE
Biochemistry; 1994 Nov; 33(46):13593-610. PubMed ID: 7947769
[TBL] [Abstract][Full Text] [Related]
10. Variation in the inhibition of restriction enzyme cleavage of lambda phage DNA produced by two covalent binding antitumor agents: anthramycin and mitomycin C.
Kaplan DJ
Biochem Biophys Res Commun; 1982 Dec; 109(3):639-48. PubMed ID: 6297483
[No Abstract] [Full Text] [Related]
11. Chemical conversion of anthramycin 11-methyl ether to didehydroanhydroanthramycin and its utilization in studies of the biosynthesis and mechanism of action of anthramycin.
Malhotra RK; Ostrander JM; Hurley LH; McInnes AG; Smith DG; Walter JA; Wright JL
J Nat Prod; 1981; 44(1):38-44. PubMed ID: 7217948
[TBL] [Abstract][Full Text] [Related]
12. In vitro and in vivo stability of anthramycin-DNA conjugate and its potential application as an anthramycin prodrug.
Hurley LH; Allen CS; Feola JM; Lubawy WC
Cancer Res; 1979 Aug; 39(8):3134-40. PubMed ID: 455297
[No Abstract] [Full Text] [Related]
13. Molecular mechanism of binding of pyrrolo(1,4)benzodiazepine antitumour agents to deoxyribonucleic acid--anthramycin and tomaymycin.
Lown JW; Joshua AV
Biochem Pharmacol; 1979 Jul; 28(13):2017-26. PubMed ID: 224883
[No Abstract] [Full Text] [Related]
14. Molecular mechanics simulations on covalent complexes between anthramycin and B DNA.
Rao SN; Singh UC; Kollman PA
J Med Chem; 1986 Dec; 29(12):2484-92. PubMed ID: 3783608
[TBL] [Abstract][Full Text] [Related]
15. Reaction of anthramycin with DNA. Biological consequences of DNA damage in normal and xeroderma pigmentosum cell.
Petrusek RL; Uhlenhopp EL; Duteau N; Hurley LH
J Biol Chem; 1982 Jun; 257(11):6207-16. PubMed ID: 7076670
[TBL] [Abstract][Full Text] [Related]
16. A theoretical investigation of the sequence specificity in the binding of the antitumor drug anthramycin to DNA.
Zakrzewska K; Pullman B
J Biomol Struct Dyn; 1986 Aug; 4(1):127-36. PubMed ID: 3271432
[TBL] [Abstract][Full Text] [Related]
17. Recognition of the DNA helix stabilizing anthramycin-N2 guanine adduct by UVRABC nuclease.
Walter RB; Pierce J; Case R; Tang MS
J Mol Biol; 1988 Oct; 203(4):939-47. PubMed ID: 3210245
[TBL] [Abstract][Full Text] [Related]
18. All atom molecular mechanics simulations on covalent complexes of anthramycin and neothramycin with deoxydecanucleotides.
Rao SN; Remers WA
J Med Chem; 1990 Jun; 33(6):1701-7. PubMed ID: 2342065
[TBL] [Abstract][Full Text] [Related]
19. Mitomycin C linked to DNA minor groove binding agents: synthesis, reductive activation, DNA binding and cross-linking properties and in vitro antitumor activity.
Paz MM; Das TA; Tomasz M
Bioorg Med Chem; 1999 Dec; 7(12):2713-26. PubMed ID: 10658576
[TBL] [Abstract][Full Text] [Related]
20. Binding of 2,7-diaminomitosene to DNA: model for the precovalent recognition of DNA by activated mitomycin C.
Kumar GS; He QY; Behr-Ventura D; Tomasz M
Biochemistry; 1995 Feb; 34(8):2662-71. PubMed ID: 7873548
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
